Anex hosts a number of committees as a way to engage in debates and to help shape drug policy – particularly as it relates to preventing drug harm in the community.
The current list of committees hosted by Anex includes:
- Anex Research Advisory Committee
- Harm Minimisation in Prisons Committee
- Anex Bulletin Editorial Reference Panel
- NSP Policy and Practice Forum
- Anex 2010 Conference Reference Group
- Safer Using Series Reference Group
- Anex Pharmacotherapy Network Meeting
- Anex NSP/PHC Network Meeting
The membership of committees includes a mix of expertise across the harm reduction community in Australia.
The Anex Research Advisory Committee
The Anex Research Advisory Committee is convened by Anex to provide advice and assistance to Anex on internal and sectoral research activities. Membership comprises:
- Professor Steve Wesselingh (Chair), Director, Infectious Diseases Unit, Monash University
- Professor Steve Allsop, Director, National Drug Research Institute
- Professor John Kaldor, Deputy Director, National Centre in HIV Epidemiology & Clinical Research
- Mr Michael Moore, Chief Executive Officer, Public Health Association Australia
- Ms Annie Madden, Chief Executive Officer, Australian Injecting and Illicit Drug Users League (AVIL)
- Professor Robert Power, Director Centre for Harm Reduction, Burnet Institute for Medical Research and Public Health
Harm Minimisation in Prisons Committee:
The Anex Harm Minimisation in Prisons Committee has been established by Anex to provide advice and assistance to Anex on its policy directions and activities in regard to improving access to NSP services in custodial settings in Australia. Membership comprises:
- Professor Nick Crofts, Nossal Institute for Global Health
- Associate Professor Kate Dolan, National Drug and Alcohol Research Centre
- Professor Michael Good AO, National Health and Medical Research Council
- Professor Margaret Hamilton AO, University of Melbourne
- Ms Annie Madden, AIVL (Australian Injecting and Illicit Drug Users League)
- Ms Helen McNeill, Hepatitis Australia
- Professor Chris Puplick AM, Former Chair of Australian National Council on AIDS, Hepatitis C and Related Diseases
- Adjunct Professor George Rubin, Royal Australian College of Physicians, Australasian Faculty of Public Health
- Mr John Ryan, Anex
- Mr Gino Vumbaca, ANCD (Australian National Council on Drugs)
- Dr Alex Wodak AM, St Vincent’s Hospital Alcohol and Drug Service
Anex Bulletin Editorial Reference Panel
The Editorial Reference Panel is established to provide editorial guidance to Anex in the development of the Anex Bulletin. The Reference Panel plays a vital role in providing high-level advice on the publication’s content and style. Membership comprises:
- Ms Cheryl Delalande, Manager Darebin Community Health Service
- Ms Sharon Dukic, Project Manager, Department of Health & Ageing
- Ms Ann Frizzell, Director, Treatment Program and Policy Section, Department of Health
- Mr Roland Jauernig, Manager, Victorian Department of Human Services
- Mr Robert Kemp Manager, Needle and Syringe Program Management Unit (NSPMU), Division of Chief Health Officer, QLD Health
- Mr Mark Lowery, Executive Officer, Western Australian Substance Users Association (WASUA)
- Mr Stephen Lymb, Manager Harm Reduction, Population Health Programs Division, Drug and Alcohol Council of South Australia
- Ms Rosemary Mason, Senior Policy Officer, NSW Health
- Mr Gregory Perry, Nurse Unit Manager, Biala Harm Reduction Centre, Metro North Health Service District, Queensland Health
- Mr Gino Vumbaca, Executive Director, Australian National Council on Drugs
NSP Policy and Practice Forum
The Anex National Needle and Syringe Program (NSP) Policy and Practice Forum has been established by Anex to provide advice on the development and implementation of Anex’s policy directions in relation to NSP, harm reduction and related issues in Australia. Membership comprises:
- Ms Jude Bevan, Senior Policy & Planning Officer, Western Australian Department of Health
- Mr Mark Denoe, Counselling Outreach Education Manager, Kirketon Road Centre
- Mr John Didlick, Coordinator, Policy Performance & Planning, ACT Health
- MsTracey Dobbie, NSP/Pharmacy Program Manager, Directions ACT
- Ms Carolyn Hay, Hepatitis C Project Officer, Tasmanian Council on AIDS, Hepatitis and Related Diseases (TASCAHRD)
- Ms Carol Holly, Manager, SA Voice for IV Education (SAVIVE)
- Mr Roland Jauernig, Manager, Victorian Department of Human Services
- Ms Tania Joughin, Team Leader, The Link Youth Health Service
- Mr Robert Kemp, Manager, Needle and Syringe Program Management Unit (NSPMU), Division of Chief Health Officer, Queensland Health
- Mr Mark Lowery, Executive Officer, West Australian Substance Users Association (WASUA)
- Mr Stephen Lymb, Manager Harm Reduction, Population Health Programs Division, Drug and Alcohol Council of South Australia
- Ms Rosmary Mason, Senior Policy Officer, NSW Health
- Ms Oanh Nguyen, BBV Policy Officer, Sexual Health & Blood Borne Virus Unit, Northern Territory Department of Health and Community Services
- Mr Gregory Perry, Nurse Unit Manager, Biala Harm Reduction Centre, Metro North Health Service District, Queensland Health
- Ms Lana Pocock, Regional Training Coordinator, Northern Territory AIDS & Hepatitis C Council (NTAHC)
- Mr Stephen Schmidtke, Executive Manager, Client Services, North Richmond Community Health
- Ms Francine Smith, State NSP Co-ordinator, Tasmanian Department of Health and Human Services
- Dr Ingrid van Beek, Director, Kirketon Road Centre
Anex 2010 Conference Reference Group
The Anex 2010 Australian Drugs Conference – Public Health and Harm Reduction has been convened to provide advice and assistance to Anex on all aspects regarding the planning, organisation, programming and delivery of the two-day Anex 2010 Conference to be held in October 2010. Membership comprises:
- Professor Steve Allsop, Director, National Drug Research Institute
- Ms Helene Delany, Manager, ACT Health
- Dr Malcolm Dobbin, Senior Medical Adviser (Alcohol and Drugs), Department of Health
- Dr Adrian Dunlop, Area Director, Hunter New England Area Health Service
- Dr Matthew Frei, Head Clinician, Eastern Access Community Health
- Ms Sophie Hibburd, Policy Officer, The Pharmacy Guild of Australia
- Mr Roland Jauernig, Manager, Victorian Department of Health
- Mr Robert Kemp, Manager, Needle and Syringe Program Management Unit (NSPMU), Queensland Health
- Ms Annie Madden, Chief Executive Officer, Australian Injecting and Illicit Drug Users League (AIVL)
- Professor Lisa Maher, Professor, National Centre in HIV Epidemiology and Clinical Research (NCHECR)
- Mr Michael Moore, Chief Executive Officer, Public Health Association Australia
- Mr David Templeman, Chief Executive Officer, Alcohol and other Drugs Council of Australia (ADCA)
- Ms Helen Tyrell, Executive Officer, Hepatitis Australia
- Dr Ingrid van Beek, Director, Kirketon Road Centre